• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

PET Staging Improves Survival in Small-Cell Lung Cancer


Using PET to stage patients with limited-stage small-cell lung cancer before treatment improves survival rate.

Patients with limited-stage small-cell lung cancer (LS-SCLC) who undergo pretreatment staging with PET showed better disease control and survival, according to a study published in the Journal of Thoracic Oncology.

In 2012, the National Comprehensive Cancer Network (NCCN) recommended that newly diagnosed patients with SCLC undergo a PET-CT, a change from their previous recommendation of a bone scan. Researchers from the University of Pennsylvania undertook a study to determine the clinical impact of the new recommendation.

Fifty-four patients with LS-SCLC who underwent concurrent chemoradiation from January 2001 to August 2010 were identified for the study. The researchers looked at the patients’ scanning history and treatment outcomes. All patients underwent thoracoabdominopelvic CT and MRI neuroimaging. Forty patients underwent PET.

The results showed that more patients who underwent PET staging presented with nodal metastases. The median overall survival from diagnosis in the patients who underwent PET before treatment was 32 months versus 17 months in patients staged without PET. Three-year survival was 47 percent (PET) versus 19 percent (non-PET).

“Pretreatment PET staging of LS-SCLC was associated with improved survival,” the authors wrote. “PET-staged patients had an improved three-year overall survival from diagnosis compared with those with LS-SCLC who were not staged with PET.”

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.